The tariff classification of a Recording Head Component from Germany
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Key passages, quoted from the ruling
- The applicable subheading for the Recording Head Component will be 9021.90.8100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “other appliances which are worn or carried, or implanted in the body, to compensate for a defect or disability; parts and accessories thereof: Other: Other.” The general rate of duty will be free.
Ruling text
In your letter dated August 14, 2026, you requested a tariff classification ruling. Additional information was provided via email dated August 21, 2026. The product under consideration is the Recording Head Component, also referred to as the Sensor and known as the Stentrode, of the Stentrode Brain-Computer Interface (BCI) System.
The Stentrode BCI System is designed to detect neural activity associated with a user’s intended movements or commands and transmit those signals to an external digital device, enabling hands-free operation for individuals with severe paralysis or motor impairment. The system allows users to control devices such as a phone, tablet, or other digital interface without relying on voluntary muscle movement.
The BCI system is intended to restore functional capabilities for individuals with severe motor impairment resulting from neurological conditions such as stroke, spinal cord injury, or amyotrophic lateral sclerosis. It functions as an implantable neuroprosthetic system that translates neural activity into digital commands, enabling users to communicate and interact with external devices.
In this way, the system is intended for clinical use or clinical investigation to improve the ability of individuals with significant disability to communicate and interact with their environment. The device does not treat or cure the underlying neurological disease or injury. Rather, it is intended to provide functional assistance by compensating for lost motor function.
The complete Stentrode BCI System consists of the Recording Head Component, the Implantable Recording and Transmitting Unit or IRT, also referred to as the receiver, and the Signal Processing Unit or SPU. The Recording Head Component consists of a self-expanding nitinol wire-mesh, stent-like frame embedded with a series of electrodes. This component is implanted in a blood vessel near the brain to detect neural signals with sufficient signal fidelity.
It records brain activity and transmits those signals to the IRT. The IRT is implanted in the patient’s chest and receives signals from the Recording Head Component. The IRT then transmits the signals by Bluetooth to the SPU for further processing. The SPU receives and processes the brain signals from the IRT before sending the processed commands to an external device, such as a phone, tablet, or other digital interface.
The Recording Head Component is packaged in plastic tubes to protect its integrity during transport from Germany to the United States. After importation, it is connected to the remainder of the finished device through a series of cables.
The applicable subheading for the Recording Head Component will be 9021.90.8100, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “other appliances which are worn or carried, or implanted in the body, to compensate for a defect or disability; parts and accessories thereof: Other: Other.” The general rate of duty will be free.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N364324).